Mankind Pharma Limited (BOM:543904)

Market Cap	898.02B
Revenue (ttm)	135.46B
Net Income (ttm)	17.51B
Shares Out	n/a
EPS (ttm)	42.63
PE Ratio	51.29
Forward PE	38.86
Dividend	1.00 (0.05%)
Ex-Dividend Date	Aug 8, 2025

Volume	3,596
Average Volume	14,481
Open	2,247.35
Previous Close	2,243.90
Day's Range	2,167.95 - 2,252.80
52-Week Range	2,090.10 - 2,753.95
Beta	n/a
RSI	45.77
Earnings Date	Feb 3, 2026

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 26,978
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.